KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Calumet (CLMT) EBT (2023 - 2025)

Calumet (CLMT) has disclosed EBT for 3 consecutive years, with -$250.5 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT fell 547.29% to -$250.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$287.8 million, a 31.66% decrease, with the full-year FY2025 number at -$242.3 million, down 5.99% from a year prior.
  • EBT was -$250.5 million for Q4 2025 at Calumet, down from $272.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $272.0 million in Q3 2025 to a low of -$250.5 million in Q4 2025.
  • A 3-year average of -$35.3 million and a median of -$38.7 million in 2024 define the central range for EBT.
  • Biggest YoY gain for EBT was 372.27% in 2025; the steepest drop was 547.29% in 2025.
  • Calumet's EBT stood at -$13.9 million in 2023, then plummeted by 178.42% to -$38.7 million in 2024, then crashed by 547.29% to -$250.5 million in 2025.
  • Per Business Quant, the three most recent readings for CLMT's EBT are -$250.5 million (Q4 2025), $272.0 million (Q3 2025), and -$147.7 million (Q2 2025).